“No medical value” in the U.S.
Though $100,000 can go quickly in scientific
research, the federal government’s generosity
helped fund these incredible discoveries.
So, after all of that funding, why is cannabis
still seen as having “no medical value” by the
DEA and other governmental agencies?
In 2013, the NIH released even a study that
described that the endocannabinoid system
plays a role in “essentially every human
disease”.
The U.S. government currently holds a patent
on cannabinoids as a neuroprotective
antioxidant, which is helpful in Alzheimer’s
and other neurodegenerative diseases.
Dr. Alan Shackelford, a Harvard-trained,
medical cannabis prescribing doctor in
Colorado, explained that the U.S. doctors had
no trouble prescribing the herb prior to the
Reefer Madness era. He tells Newsweek,
Marijuana was an integral part of American
medicine for more than 100 years, from the
1830s through the 1940s, and it was used
safely and effectively for all of that time. –
Shackelford
What gives?
So, what’s with all of the hypocrisy?
Recently, large pharmaceutical companies
have made substantial donations to anti-
legalisation campaigns. At the same time,
other companies have received special
permission
to
test
cannabis-based
pharmaceuticals in U.S. patients.
Yet, everyday doctors who wish to prescribe
the herb cannot since the herb has Schedule 1
status.
All but a select few independent and
pharmaceutical researchers are blocked from
experimenting with cannabis on U.S. soil.
Though the federal government has respected
state rights thus far, patients, recommending
doctors, and cannabis businesses are still
shunned to remain in a grey area of the law.
With all of this evidence, it’s time for real
change.
Already, many of the U.S. states have
implemented some form of cannabis reform.
With the majority in favour, why is there still
a delay?
https://herb.co/marijuana/news/israeli-
cannabis-research/